The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(3-propionamidophenyl)-2-(m-tolyloxy)propanamide ID: ALA4175827
PubChem CID: 17188268
Max Phase: Preclinical
Molecular Formula: C19H22N2O3
Molecular Weight: 326.40
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CCC(=O)Nc1cccc(NC(=O)C(C)Oc2cccc(C)c2)c1
Standard InChI: InChI=1S/C19H22N2O3/c1-4-18(22)20-15-8-6-9-16(12-15)21-19(23)14(3)24-17-10-5-7-13(2)11-17/h5-12,14H,4H2,1-3H3,(H,20,22)(H,21,23)
Standard InChI Key: SJPWPLFGPBZWFI-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 25 0 0 0 0 0 0 0 0999 V2000
16.8129 -11.5768 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.8118 -12.3964 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.5198 -12.8053 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.2295 -12.3959 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.2266 -11.5732 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.5180 -11.1680 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.5156 -10.3508 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.9378 -12.8034 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.6449 -12.3937 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.3532 -12.8012 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.6436 -11.5765 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.3545 -13.6184 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.0603 -12.3915 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.7687 -12.7989 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.7655 -13.6168 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.4730 -14.0242 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.1811 -13.6144 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.1772 -12.7930 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.4691 -12.3893 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.8828 -12.3808 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
24.5926 -12.7858 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.2982 -12.3736 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.5967 -13.6030 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
26.0080 -12.7786 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
6 7 1 0
4 8 1 0
8 9 1 0
9 10 1 0
9 11 1 0
10 12 2 0
10 13 1 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 14 1 0
18 20 1 0
20 21 1 0
21 22 1 0
21 23 2 0
22 24 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 326.40Molecular Weight (Monoisotopic): 326.1630AlogP: 3.75#Rotatable Bonds: 6Polar Surface Area: 67.43Molecular Species: NEUTRALHBA: 3HBD: 2#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 12.57CX Basic pKa: ┄CX LogP: 3.75CX LogD: 3.75Aromatic Rings: 2Heavy Atoms: 24QED Weighted: 0.85Np Likeness Score: -1.83
References 1. Xiong H, Han J, Wang J, Lu W, Wang C, Chen Y, Fulin Lian, Zhang N, Liu YC, Zhang C, Ding H, Jiang H, Lu W, Luo C, Zhou B.. (2018) Discovery of 1,8-acridinedione derivatives as novel GCN5 inhibitors via high throughput screening., 151 [PMID:29665527 ] [10.1016/j.ejmech.2018.02.005 ]